Tất cả tài liệu

Phase I clinical study of brentuximab vedotin (SGN-35) involving children with recurrent or refractory CD30-positive Hodgkin's lymphoma or systemic anaplastic large cell lymphoma: rationale, design and methods of BV-HLALCL study: Study protocol

8 trang

Ebook Veterinary comparative hematopathology: Part 2

284 trang